Examples of using Was based on data in English and their translations into Vietnamese
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
This research was based on data of 20,000 men monitored for more than two decades.
The approval by Australia's Therapeutic Goods Association was based on data generated by Dr. Keech and colleagues.
The report was based on data from a survey of 3,000 people in the United States and United Kingdom.
Our study, conducted at Aarhus University andpublished in the journal Open Heart this week, was based on data from nearly one million patients.
The report was based on data voluntarily submitted by about 15,000 law enforcement agencies.
The CDC did not give reasons for the hike in estimates but said the study by it andglobal health partners was based on data from a larger, more diverse sample of countries than previously.
The report was based on data collected from investor visa programme statistics of each country;
The study, carried out by researchers from the National Institutes of Health andOhio State University, was based on data from the Longitudinal Investigation of Fertility and the Environment(LIFE) Study.
The new study was based on data from more than 6,000 Finnish patients who were followed for up to 32 years.
GlaxoSmithKline reported a greater incidence of fractures of the upper arms, hands and feet in female diabetics given rosiglitazone compared with those given metformin or glyburide.[38]The information was based on data from the ADOPT trial[39] The same increase has been found with pioglitazone(Actos), another thiazolidinedione.
This was based on data from more than 100,000 phones downloading an image in large U.S. cities.
The study, published in the journal Jama Network Open, was based on data from more than 300,000 Americans aged 50-71 who undertook a questionnaire in the mid-1990s.
Tholen, and was based on data collected from an eight-color asteroid survey performed in the 1980s.
The magazine was based on data from industry publications, as well as conversations with experts and some stars.
This year's index was based on data from 2007 and does not take into account the impact of the global economic crisis.
The report was based on data from a survey of 413 people in the United States who own a business with fewer than 500 employees.
Approval was based on data from 83 patients with relapsed refractory multiple myeloma who received Xpovio and dexamethasone.
The study was based on data from more than 88,000 U.S. adults who participated in the National Health Interview Survey between 1997 and 2008.
Ghosh's study was based on data from more than 2,000 companies that received venture funding, generally at least $1m, from 2004 through 2010.
The report was based on data from a survey of 220 marketers and 559 creatives(defined as writers, designers, and developers who create content for marketers).
The approval was based on data from the randomised, open-label, Phase III OlympiAD trial which tested Lynparza vs. physician's choice of chemotherapy(capecitabine, eribulin, or vinorelbine).
About the research: The report was based on data from a survey of 1,036 marketers, social media strategists, C-Level executives, and entrepreneurs conducted February 10-13, 2014.
The report was based on data from a survey conducted in June 2016 of 200 marketing executives randomly selected from companies with 100 or more employees, and 200 advertising executives randomly selected from agencies with 20 or more employees.
The study was based on data gathered from three large ongoing surveys, including some 300,000 nurses and other health professionals who agree to answer questionnaires about their own medical conditions and habits at regular intervals over the course of 30 years.
The FDA approval was based on data from a phase 3 immunogenicity and safety study in which the influenza vaccine achieved the primary endpoint of non-inferior immunogenicity compared with 2 trivalent formulations of the vaccination, each containing 1 of the 2 influenza B strains recommended for the inclusion of the vaccine for the 2017-2018 influenza season.
FDA approval was based on data from a Phase 3 immunogenicity and safety study, in which Fluzone High-Dose Quadrivalent achieved the primary endpoint of non-inferior immunogenicity compared to two trivalent formulations of Fluzone High-Dose, each containing one of the two influenza B strains recommended for inclusion in the vaccine for the 2017-2018 influenza season.
This FDA approval was based on data from a Phase 3 immunogenicity and safety study published in Vaccine in September 2019, in which Fluzone High-Dose Quadrivalent achieved the primary endpoint of non-inferior immunogenicity compared to 2 trivalent formulations of Fluzone High-Dose, each containing one of the 2 influenza B strains recommended for inclusion in the vaccine for the 2017-2018 influenza season.